Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 327 of 6351
-
Bladder cancer trial aims to save more of the bladder
Disease control Recruiting nowThe goal of this clinical trial is to determine if a partial cystectomy with extended pelvic lymph node removal will be effective at treating Muscle-Invasive Bladder Cancer instead of a complete cystectomy with extended pelvic lymph node removal. This clinical trial aims to deter…
Phase 2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New hope for Wake-Up stroke patients: drug may boost recovery
Disease control Not yet recruitingThe benefit of intravenous tenecteplase for acute ischemic stroke with unknown time of onset, e.g. wake-up stroke, remains uncertain. This randomized study aims to assess the efficacy and safety of intravenous tenecteplase following non-contrast CT screening for acute ischemic st…
Phase 3 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
CLL patients may get a break from daily pills
Disease control Not yet recruitingThis Phase II hybrid decentralized multicenter study examines the outcomes of stopping Bruton tyrosine kinase inhibitor (BTKi) therapy in patients with chronic lymphocytic leukemia (CLL) who have remained in remission for at least two years. The primary objective is to determine …
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Chemo-free triplet aims to outsmart incurable lymphoma
Disease control Not yet recruitingFollicular lymphoma (FL) remains an incurable indolent B-cell lymphoma for many patients, and although rituximab-based chemoimmunotherapy can achieve high initial response rates, a substantial proportion of patients experience early progression, including POD24, which is associat…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug cocktail aims to tame rare lung cancer
Disease control Not yet recruitingThis phase II clinical trial evaluates the efficacy, safety and tolerability of Obrixtamig in addition to standard of care chemotherapy (Platinum/Etoposide) in LCNEC.
Phase 2 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Could a 'Vaginal microbiome Transplant' stop recurring BV?
Disease control Not yet recruitingThe MOTIF@ FRESH trial will assess the safety and efficacy of "vaginal microbiome transplantation" (VMT). Healthy females will be enrolled to donate vaginal fluid which will be processed and transplanted in females with a history of recurrent bacterial vaginosis (BV), treated wit…
Phase 2 • Sponsor: Douglas Kwon • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could the time of day you get immunotherapy boost its power against melanoma?
Disease control Not yet recruitingMelanoma remains a common cancer with rising incidence, and despite significant improvements with immune checkpoint inhibitors (ICIs), clinical outcomes remain heterogeneous. Retrospective analyses across multiple tumor types, including melanoma, suggest that earlier daytime admi…
Phase 2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Heart procedure may offer lasting migraine relief, new study hopes to prove
Symptom relief Not yet recruitingMigraine is a common and often disabling condition, but its exact causes are not fully understood. Some people with migraines have a small opening in the heart wall called a patent foramen ovale (PFO). In some of these patients, closing this opening or taking a medication that in…
Phase 3 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Can a school-based trauma program keep incarcerated teens from turning to drugs?
Disease control Not yet recruitingThis pilot study, conducted in partnership with juvenile detention centers, evaluates an adapted CBITS-RTM intervention delivered in a detention school setting.
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New strategies aim to boost lung cancer screening and save lives
Prevention Not yet recruitingLung cancer screening (LCS) with low-dose computed tomography (LDCT) can reduce the risk of dying from lung cancer, but many people who are eligible for screening do not receive it. The purpose of the Empower LCS/Call+ study is to evaluate new strategies to improve lung cancer sc…
Sponsor: University of California, Irvine • Aim: Prevention
Last updated Jul 24, 2026 00:00 UTC
-
Could a weekly shot help more people donate part of their liver?
Disease control Not yet recruitingThe purpose of this study is to evaluate the efficacy and safety of a short-term (12-week) prehabilitation strategy combining mazdutide (a novel GLP-1/GCG receptor dual agonist) with lifestyle optimization, compared to lifestyle optimization alone, in potential living liver trans…
Phase 2/3 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Can Real-Time MRI make radiation safer for Ultra-Central lung tumors?
Disease control Not yet recruitingPhase II multicenter trial evaluating the safety, tolerability, and feasibility of MRI-guided stereotactic radiotherapy using MRI-LINAC in patients with ultracentral lung tumors or lymphadenopathy in the context of controlled oligometastatic disease. The study investigates the po…
Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Sound waves and microbubbles: a new key to the Brain's locked door?
Disease control Not yet recruitingCAMPSIS is a preliminary feasibility study of the TheraOne medical device (IIb). TheraOne is an active, non-invasive medical device intended to deliver transcranial FUS in combination with intravenous microbubbles in order to transiently and locally induce the BBB permeability. …
Phase 1 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a new painkiller prevent breathing crises after surgery?
Disease control Not yet recruitingOpioids are frequently used for postoperative analgesia but may induce side effects. Opioid-induced respiratory depression is the most dangerous side effect of opioids. Patients with obstructive sleep apnea (OSA) are at higher risk for opioid-induced respiratory depression. Olice…
Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could blocking an extra nerve double migraine relief?
Symptom relief Not yet recruitingMigraine is one of the most prevalent neurological disorders worldwide and remains a leading cause of disability, particularly among individuals of working age. Chronic migraine affects approximately 1-2% of the global population and is associated with substantial impairment in q…
Phase 4 • Sponsor: Assiut University • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Can a simple CT scan catch lung cancer earlier in kuwait?
Diagnosis Not yet recruitingLung cancer is a leading cause of cancer-related death in Kuwait, where most cases are diagnosed at an advanced stage and there is no national screening program. This prospective pilot feasibility study will offer low-dose computed tomography (LDCT) screening to approximately 500…
Sponsor: Sulaiman Khadadah • Aim: Diagnosis
Last updated Aug 19, 2026 00:00 UTC
-
Massage therapy may offer a Drug-Free path to better sleep
Symptom relief Not yet recruitingThis randomized controlled trial will investigate the effects of connective tissue massage on insomnia severity, objective and subjective sleep outcomes, and stress- and autonomic-related biomarkers in adults with chronic insomnia. Chronic insomnia is a common sleep disorder char…
Sponsor: Saglik Bilimleri Universitesi • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Can cutting semaglutide dose still keep the weight off?
Disease control Not yet recruitingThe goal of this clinical trial is to determine whether a semaglutide dose-tapering regimen is non-inferior to a treatment-dose maintenance regimen for weight-loss maintenance in adults with overweight or obesity who have achieved stable weight loss. This trial will also evaluate…
Phase 4 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can a new imaging tracer light up ovarian cancer cells?
Diagnosis Not yet recruitingEpithelial ovarian cancer (EOC) is the fifth leading cause of cancer-related death in women, with approximately 320,000 new cases and 200,000 deaths annually worldwide, and its incidence is rising. Current treatment mainly relies on surgery, chemotherapy, and radiotherapy, but EO…
Early phase 1 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Diagnosis
Last updated Aug 29, 2026 00:00 UTC
-
Can a smarter ventilator setting spare damaged lungs on ECMO?
Disease control Not yet recruitingThe purpose of this study is to find a better way to protect the lungs of patients with Acute Respiratory Distress Syndrome (ARDS) who are being treated with a mechanical ventilator in addition to an extracorporeal membrane oxygenation (ECMO) machine. ARDS is a serious lung condi…
Sponsor: University of Virginia • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC